KIMINI MEDICAL PTE. LTD.

Self-executable and Painless Blood Sampling Device

KIMINI MEDICAL PTE. LTD. is a business in medtech based in Singapore, founded in 2026.

Profile

Kimini is a Singapore-based medtech company developing a novel blood sampling device that enables accurate, low-pain capillary blood collection for routine clinical diagnostics and decentralized testing. The device addresses limitations of conventional venipuncture, including patient discomfort, reliance on trained phlebotomists, and limited accessibility in outpatient, home, and resource-constrained settings.

The core innovation is a controlled micro-sampling mechanism designed to improve sample consistency and reduce pre-analytical variability, with the objective of achieving clinical equivalence to venous blood for common biochemical and immunoassay tests. The device is designed for ease of use, safety, and scalability, while remaining compatible with existing laboratory workflows and analyzers.

The initial target customers are diagnostic laboratories, clinics, and hospitals seeking to expand point-of-care and decentralized testing without compromising analytical reliability. Longer-term applications include home testing, chronic disease monitoring, and population screening.

The company plans to progress from prototype validation to regulatory approval in Singapore and ASEAN, followed by commercialization through partnerships with clinical laboratories and healthcare providers.

KIMINI MEDICAL PTE. LTD. is positioned in medtech, a segment that rewards a clear, focused offering.

Singapore is where the company is located.

Its current recorded stage is Startup SG directory startup.

Recorded headcount: 1 - 10 employees.

Website: kimini-med.com